Davide Brenna

Title: Davide Brenna: Innovator in Topical Anti-Inflammatory Agents

Introduction

Davide Brenna is a notable inventor based in Baranzate, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical anti-inflammatory agents. His innovative work has led to the creation of a patented process that enhances the preparation of these important medications.

Latest Patents

Davide Brenna holds a patent for "Intermediates and process for the preparation of a crystalline form of a topical anti-inflammatory agent." This invention relates to a process for the preparation of an inhibitor of phosphodiesterase 4, specifically phosphodiesterase 4B (PDE4B). The patent outlines the intermediates that are useful for the preparation of this inhibitor, showcasing Brenna's expertise in pharmaceutical chemistry.

Career Highlights

Brenna is currently associated with Dipharma Francis S.r.l., a company that focuses on the development and production of pharmaceutical intermediates and active ingredients. His role at the company allows him to apply his innovative ideas in a practical setting, contributing to the advancement of medical treatments.

Collaborations

Throughout his career, Davide Brenna has collaborated with talented professionals in the field, including Niccolò Santillo and Emanuele Attolino. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of new solutions in pharmaceutical science.

Conclusion

Davide Brenna's contributions to the field of pharmaceuticals, particularly through his patented processes, highlight his role as an innovator in the industry. His work continues to impact the development of effective treatments for inflammatory conditions.